Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hubbard

Showing results (451-460 of 562) with videos related to

Pageof 57
Sort By:
Elife|June 25, 2020
Mitigating memory effects during undulatory locomotion on hysteretic materialsPerrin E Schiebel, Henry C Astley, Jennifer M Rieser, et al.
Biomacromolecules|April 4, 2017
Evaluation of the Antimicrobial Activity of Cationic Polymers against Mycobacteria: Toward Antitubercular MacromoleculesDaniel J Phillips, James Harrison, Sarah-Jane Richards, et al.
Thrombosis Update|April 15, 2024
Enhanced thromboprophylaxis in critically ill patients with COVID-19 infectionR L Kummer, K A Considine, M A Rankin, et al.
The Oncologist|April 21, 2018
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic ExperienceZhaohui Jin, Cristobal T Sanhueza, Benny Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPPD L Longo, P L Duffey, V T DeVita, et al.
Plos One|October 28, 2021
Diet of a threatened endemic fox reveals variation in sandy beach resource use on California Channel IslandsHenry M Page, Juliann Schamel, Kyle A Emery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Therapeutic Advances in Medical Oncology|March 24, 2020
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)Hao Xie, Jacqueline M Lafky, Bruce W Morlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Cancers|July 29, 2023
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution AnalysisMichael H Storandt, Kara R Rogen, Anushka Iyyangar, et al.
Pageof 57

Showing results (451-460 of 562) with videos related to

Sort By:
Pageof 57
Elife|June 25, 2020
Mitigating memory effects during undulatory locomotion on hysteretic materialsPerrin E Schiebel, Henry C Astley, Jennifer M Rieser, et al.
Biomacromolecules|April 4, 2017
Evaluation of the Antimicrobial Activity of Cationic Polymers against Mycobacteria: Toward Antitubercular MacromoleculesDaniel J Phillips, James Harrison, Sarah-Jane Richards, et al.
Thrombosis Update|April 15, 2024
Enhanced thromboprophylaxis in critically ill patients with COVID-19 infectionR L Kummer, K A Considine, M A Rankin, et al.
The Oncologist|April 21, 2018
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic ExperienceZhaohui Jin, Cristobal T Sanhueza, Benny Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPPD L Longo, P L Duffey, V T DeVita, et al.
Plos One|October 28, 2021
Diet of a threatened endemic fox reveals variation in sandy beach resource use on California Channel IslandsHenry M Page, Juliann Schamel, Kyle A Emery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Therapeutic Advances in Medical Oncology|March 24, 2020
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)Hao Xie, Jacqueline M Lafky, Bruce W Morlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Cancers|July 29, 2023
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution AnalysisMichael H Storandt, Kara R Rogen, Anushka Iyyangar, et al.
Pageof 57